欢迎访问《中国循证儿科杂志》官方网站，今天是
English Version
中国循证儿科杂志

中国循证儿科杂志 ›› 2017, Vol. 12 ›› Issue (3): 175-179.

• 论著 • 上一篇    下一篇

早产儿经鼻高流量氧疗安全性和有效性的系统评价和Meta 分析

唐琴琴1,徐丁1,王凡1,岳伟岗2,田金徽3，4   

  1. 1兰州大学第二医院 兰州，730000；2兰州大学第一医院 兰州，730000；3兰州大学循证医学中心 兰州，730000；4甘肃省循证医学与临床转化重点实验室 兰州，730000
  • 收稿日期:2017-04-28 修回日期:2017-06-25 出版日期:2017-06-25 发布日期:2017-06-25
  • 通讯作者: 徐丁

The efficacy and safety of high-flow nasal cannulae oxygen therapy in premature infants: a meta-analysis

TANG Qin-qin1, XU Ding1, WANG Fan1, YUE Wei-gang2, TIAN Jin-hui3,4   

  1. 1 The Second Hospital of Lanzhou University; Lanzhou 730000, China; 2 The First Hospital of Lanzhou University; Lanzhou 730000, China; 3 Evidence Based  Medicine Center of  Lanzhou University; Lanzhou 730000, China; 4 Key Laboratory of  Evidence Based Medicine and Clinical Transformation of  GanSu Province, Lanzhou 730000, China
  • Received:2017-04-28 Revised:2017-06-25 Online:2017-06-25 Published:2017-06-25
  • Contact: XU-Ding

PDF

1398

被引次数

8

摘要：

目的：评价经鼻高流量氧疗（HFNC）用于早产儿的安全性和有效性。方法：计算机检索中国知网、中国生物医学文献数据库、维普数据库、万方数据库、Medline、Embase、Web of Sience和the Cochrane Library，收集早产儿应用 HFNC（HFNC组）和经鼻持续气道正压通气（NCPAP组）的RCT，检索时间为建库至2017 年 3月31 日。主要结局指标：住院病死率和治疗失败需有创机械通气（气管插管）率；次要结局指标：支气管肺发育不良（BPD）、气漏、肺部感染和鼻部损伤的发生率，肺表面活性物质的应用率。结果：8篇文献1 604 例患儿进入本文Meta分析，HFNC 组799例，NCPAP 组 805 例。8篇均报告了计算机随机序列产生，7篇采用分配隐藏， 8篇文献均无失访、数据完整性好、研究结果无选择性报告，其他偏倚不清楚。两组病死率和气管插管率差异均无统计学意义。病死率行亚组分析，差异仍无统计学意义。气管插管率行亚组分析显示，体重均数≥1 500 g（OR=1.58,95％CI：1.11～2.26，P=0.01）和胎龄≥28周（OR=1.58,95％CI：1.13～2.22，P=0.008），NCPAP组气管插管率低于HFNC组。BPD、气漏、肺部感染发生率和肺表面活性物质应用率，两组差异无统计学意义。HFNC组鼻部损伤发生率低于NCPAP组（OR=-0.14,95％CI：-0.19～-0.09，P＜0.0001）。结论：HFNC应用于早产儿的疗效和安全性有待进一步证实，其鼻部损伤发生率低于NCPAP。

关键词: Meta分析, 经鼻持续气道正压通气, 经鼻高流量氧疗, 早产儿

Abstract:

Objective: To evaluate the efficacy and safety of high-flow nasal Cannulae (HFNC) oxygen therapy in premature infants. Methods: RCT studies were identified by a systematic search in Medline, the Cochrane Library, Web of Science, Embase, Chinese Knowledge Network, VIP, CBM and Wanfang database, from its establishment to March 31, 2017. The primary outcome was hospital mortality and the incidence of mechanical ventilation (tracheal intubation). The secondary outcome included BPD, air leakage, pulmonary infection, nasal trauma,and application of pulmonary surfactant. Results: Eight articles were included in the metaanalysis, and 1 604 children were included, including 799 cases in HFNC group, 805 cases in NCPAP group. 8 articles were reported in the random sequence of the computer, 7 mentioned the use of the allocation of hidden, 8 papers were lost, data integrity was good, the Results: of the reports were not selective, other bias was not clear. There was no significant difference in mortality and intubation rate between the two groups. The tracheal intubation rate of NCPAP was lower than HFNC group in children with mean weight ≥1 500 g（OR=1.58,95％CI：1.11～2.26，P=0.01）and gestational age more than 28 weeks（OR=1.58,95％CI：1.13～2.22，P=0.008）.There was no significant difference in the incidences of BPD, air leakage and pulmonary infection and the rate of pulmonary surfactant application between the two groups.The incidence of nasal trauma HFNC group was lower than that of NCPAP （OR=-0.14,95％CI：-0.19～-0.09，P＜0.0001）.ConclusionThe efficacy and safety of HFNC in premature infants should be further confirmed, but it has obvious advantages in reducing the incidence of nasal injury.

Key words: High-flow nasal cannulae, Meta-analysis, Nasal continuous positive airway pressure, Premature infants